INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Nov 20, 2012 |
SVP Res and Devel Sciences
|
SVP Res and Devel Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 37,500 | $16.80 | 104,219 |
Aug 21, 2023 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 50,000 | $399.66 | 103,100 |
Nov 20, 2012 |
SVP Res and Devel Sciences
|
SVP Res and Devel Sciences | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 3,768 | $167.17 | 100,451 |
Feb 14, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Open market or private sale of non-derivative or derivative security | 8,510 | $109.61 | 100,212 |
May 10, 2013 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 4,527 | $268.40 | 99,899 |
Aug 28, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 40,000 | $21.92 | 99,121 |
May 13, 2019 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | -- | 98,079 |
Jun 18, 2012 |
SVP Res & Dev Sciences
|
SVP Res & Dev Sciences | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 39,411 | $115.29 | 98,032 |
Nov 05, 2015 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 75,000 | $30.63 | 97,029 |
Dec 17, 2007 |
SVP, Research & Devel Sciences
|
SVP, Research & Devel Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 95,438 | -- | 95,438 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.